MALAT1 and breast carcinoma: The relapse-freesurvival of breast cancer patients with upregulated expression of this gene waslower in 95% of cases (HR = 1.97; 95% CI 1.25–3.09; p =0.003), and no association between MALAT1 expression and lymphatic metastasiswas detected (OR = 1.32; 95% CI 0.34–5.21) [73].